Oscar Health reported second-quarter 2026 results showing a shift from a prior-year loss to net income of US$361.81 million and lifted its full-year 2026 guidance to total revenue of US$18.70–US$19.00 billion and earnings from operations of US$500–US$700 million. This combination of a profit turnaround and a sizeable upgrade to operating earnings expectations suggests Oscar’s underlying operations are running more efficiently than previously anticipated. We’ll now examine how Oscar’s...
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Chevron (CVX) has moved into the spotlight after reporting its highest quarterly earnings in six years, with profits tied to Middle Eastern supply disruptions and fresh criticism over windfall gains and elevated fuel prices. See our latest analysis for Chevron. Chevron’s share price has eased in the very short term, with a 1-day share price return of 2.10% and a 7-day share price return of 2.84%. Recent momentum remains positive given a 30-day share price return of 10.89%, a year to date...
Aeva stock is speculative -- but investors are speculating hard after last night's earnings beat.
Datadog (NASDAQ:DDOG) reported second-quarter revenue of $1.12 billion, up 36% from a year earlier and above the high end of its guidance range, as growth accelerated across both AI-focused and non-AI customers. Co-founder and Chief Executive Officer Olivier Pomel said revenue growth among non-AI c
KDP's Q2 earnings and sales beat estimates as JDE Peet's acquisition, U.S. Refreshment Beverages growth and efficiency initiatives lift performance.
Restaurant Brands International (TSX:QSR, NYSE:QSR) reported second quarter 2026 adjusted earnings above Wall Street expectations on Thursday, supported by stronger comparable sales led by Burger King in the US. The company posted adjusted diluted earnings of $1.07 per share, above the $1.03...
Pfizer carries one of Big Pharma's fattest yields while Merck burns cash on deals to secure its next growth era. Which trade-off actually serves income investors better after both companies reported earnings?
Airship AI Holdings, Inc. (AISP) delivered earnings and revenue surprises of -33.33% and -17.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
PPL heads into Q2 earnings with revenue and EPS growth expected, supported by higher power demand and rates, but a premium valuation warrants caution.
Vishay Precision Group's Q2 earnings and revenues miss estimates despite higher sales, while strong bookings, backlog growth and AI-driven demand remain tailwinds.
DOX matches Q3 FY26 earnings estimates as managed services hit record sales and fiscal 2026 targets remain intact.
Magna's Q2 earnings beat estimates as Power & Vision margin expansion and productivity gains supported higher profit and raised 2026 guidance.
CEG's Q2 adjusted earnings rise 33.5% and beat estimates as Calpine and portfolio gains lift results, prompting a higher 2026 outlook.
GTX's Q2 earnings and sales beat estimates on broad-based growth. Margin gains and productivity drove a raised 2026 outlook.
McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.
Exelixis beats EPS estimates but misses on revenues; cuts 2026 outlook as a slower-than-expected NET launch weighs on expectations.
The AI revolution is alive and well, and Western Digital stock is doing swell.
VST heads into Q2 with sharply higher revenue and EPS estimates, backed by clean-power demand, hedging, nuclear assets and Lotus contributions.
CGNX's Q2 earnings beat estimates as margin gains, favorable mix and cost control offset a slight revenue miss. The company raises 2026 guidance.
EZPW tops Q3 earnings and revenue estimates as pawn service charges, merchandise and jewelry scrap sales climb despite higher expenses.
By Jarrett Banks Corpay (NYSE: CPAY) delivered another strong quarter of double-digit organic revenue growth. But increasingly, investors are keyed into management’s capital allocation strategy as a top reason to own the stock. Several analyst notes pointed out that Corpay is evolving into one of the payments industry’s premier capital compounders. JPMorgan said investors should […] The post Corpay’s Price Target Raised by Brokers After Earnings Beat appeared first on ExecEdge.
NYT's Q2 earnings beat estimates as digital subscriptions, higher ARPU and rising digital ads fueled revenue growth.
CPAY's Q2 earnings and revenues beat estimates as Corporate Payments surge, margins expand and the 2026 profit guidance increases.
Editas beats Q2 estimates as collaboration revenues surge, while EDIT-401 advanced toward clinical testing with encouraging preclinical data.
MUR's Q2 earnings beat estimates as stronger oil prices, broad production and lower operating costs lift revenues and cash flow.
AGCO shares fall 11% after Q2 earnings and revenues miss estimates, while weaker industry conditions prompt the company to lower its 2026 outlook.
Fiserv's Q2 revenues miss estimates and margin pressure leads to an earnings miss and cuts in its 2026 growth and profit outlook.
CAVA heads into Q2 earnings with strong traffic, new restaurant growth and menu innovation in focus as investors watch for another earnings beat.